• The New Money
  • Posts
  • Hyperliquid And The Public Markets, Clean Water From SMRs, And The Startup Preventing School Shootings

Hyperliquid And The Public Markets, Clean Water From SMRs, And The Startup Preventing School Shootings

The markets and trends that matter, made simple. Discover what’s next.

Are The Public Markets Coming After Hyperliquid Next?

Multiple publicly traded companies in North America have begun acquiring popular cryptocurrency Hyperliquid to hold directly as an asset, and are announcing aggressive capital raises to focus on providing exposure to Hyperliquid through the public markets. Hyperliquid has been on an explosive growth trajectory, quickly becoming one of the most popular decentralized exchanges in all of crypto and one of the single largest tokens by market capitalization.

NuScale Wants To Produce Clean Water With Small Modular Reactors

NuScale Power (NYSE: SMR) officially announced new research programs that are aiming to use their small modular reactor technology for the production of both clean water and hydrogen. The company publicly stated that one individual NuScale Power Module is capable of producing 150 million gallons of clean water per day without producing any carbon emissions whatsoever.

Brett Adcock Is Putting Up Millions To Prevent School Shootings

Brett Adcock is the founder of electric air taxi company Archer Aviation (NYSE: ACHR) and humanoid robotics startup Figure. He is now putting $10 million into his startup Cover, which is building leading edge weapons detection technology to be able to detect concealed weapons in public spaces and is initially focused on preventing school shootings in the United States of America.

The New Money App has officially launched. Discover the world’s most exciting stocks, easier than ever before.

The Sprint

The Markets This Week

+80.2% | Circle

+75.0% | Arqit Quantum

+70.5% | Eyenovia

Top Trends This Week

+6.4% | Cathie Wood

Looking to connect? Reach out and get in touch.

New here? Join our community of 40,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.